Member Login
Search

LUGPA Policy Brief: Final Rule on the No Surprises Act Independent Dispute Resolution (IDR) Process

June 2026 

At-a-Glance

What's Changing

The Administration has finalized updates to the federal Independent Dispute Resolution (IDR) process under the No Surprises Act. The rule focuses on reducing ineligible disputes, improving provider-payer communications, enhancing the federal IDR portal, and lowering certain filing fees.

Why It Matters

The IDR system has received far more disputes than originally projected, creating administrative challenges for providers, payers, and regulators. The rule aims to improve program administration without significantly changing the arbitration framework.

Impact on Urology Practices

The changes may reduce administrative burden and improve access to the IDR process, particularly for smaller and independent practices. However, broader debates regarding reimbursement levels and future reforms remain unresolved.

Key Takeaway

The final rule makes operational improvements to the IDR process but does not fundamentally alter how payment disputes are resolved.

Executive Summary

The Administration has finalized a rule updating the federal IDR process established under the No Surprises Act. The changes are intended to improve efficiency, reduce ineligible disputes, standardize communications, and enhance portal functionality.

Provider organizations generally view the updates as positive administrative improvements. Payer and employer groups argue the rule does not address underlying concerns regarding dispute volume and arbitration outcomes.

For urology practices, the rule may modestly improve access to the IDR process while reducing administrative burden. Additional legislative or regulatory activity remains possible as policymakers continue evaluating the program.

Background

The No Surprises Act protects patients from certain unexpected out-of-network medical bills and established the federal IDR process to resolve payment disputes between providers and health plans.

Use of the IDR system has significantly exceeded initial expectations. Federal data show dispute volumes have grown substantially beyond original projections, fueling ongoing debate about the program's efficiency and long-term sustainability.

Providers argue that arbitration outcomes help ensure fair reimbursement when payment offers are inadequate. Payers contend that high dispute volumes and arbitration awards contribute to rising healthcare costs.

Key Provisions

Reducing Ineligible Disputes

The rule strengthens procedures to identify and remove disputes that do not qualify for the federal IDR process.

Standardized Communications

New requirements are intended to improve consistency and transparency in communications between providers and payers before arbitration.

Federal Portal Improvements

The Departments overseeing the program will implement technical enhancements to improve the functionality and usability of the federal IDR portal.

Filing Fee Adjustments

Lower filing fees may improve access to the IDR process for smaller physician practices and independent providers.

What the Rule Does Not Change

The final rule does not adopt several reforms sought by payer organizations, including:

  • Additional oversight of certified arbiters.
  • Expanded disclosure requirements regarding arbiter relationships or compensation.
  • New limits on arbitration awards.
  • New appeal mechanisms for arbitration decisions.

As a result, many broader policy debates surrounding the IDR process remain unresolved.

Implications for Urology Practices

Opportunities

  • Lower filing fees may make participation more practical for smaller practices.
  • Standardized communications may reduce administrative burden.
  • Portal improvements may streamline dispute management.

Considerations

  • Continued high dispute volume could prompt future reforms.
  • Payers may adjust contracting and reimbursement strategies.
  • High-cost procedural services may continue to receive increased scrutiny in payment disputes.

Practices should continue to maintain thorough documentation, review IDR workflows, monitor payer reimbursement trends, and evaluate the cost-effectiveness of pursuing arbitration.

LUGPA Perspective

LUGPA supports the patient protections established under the No Surprises Act and believes payment disputes should be resolved through fair, transparent, and efficient processes that recognize the value of specialty physician services.

While the final rule improves administration of the IDR program, important questions regarding reimbursement methodologies, dispute volume, and long-term sustainability remain under discussion.

Looking Ahead

The final rule improves several operational aspects of the federal IDR process but leaves many larger policy questions unresolved. LUGPA will continue to monitor implementation and advocate for policies that protect patients, preserve access to specialty care, and support fair physician reimbursement.